|Titre :||2017 National drug threat assessment|
|Auteurs :||US Department of Justice ; Drug Enforcement Administration|
|Type de document :||Rapport|
|Année de publication :||2017|
|Format :||182 p. / ann. ; graph. ; ill. ; tabl.|
|Discipline :||MAR (Marché de la drogue / Drug market)|
Thésaurus TOXIBASESURDOSE ; MORTALITE ; PRODUIT ILLICITE ; OPIOIDES ; EVOLUTION ; DROGUES DE SYNTHESE ; FENTANYLOIDES ; METHAMPHETAMINE ; COCAINE ; MARCHE DE LA DROGUE ; ORGANISATION CRIMINELLE ; TRAFIC INTERNATIONAL ; HEROINE ; CANNABIS ; DISPOSITIF DE SOIN ; ADMISSION ; DIFFUSION DES PRODUITS
Thésaurus GéographiqueETATS-UNIS ; MEXIQUE ; COLOMBIE
The 2017 National Drug Threat Assessment (NDTA) outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs.
Over the past 10 years, the drug landscape in the United States has shifted, with the opioid threat - including controlled prescription drugs (CPDs), fentanyl and other synthetic opioids, and heroin - reaching epidemic levels and impacting significant portions of the United States. While the current opioid crisis has received significant attention, other drugs of abuse remain prevalent. These include methamphetamine, cocaine, new psychoactive substances (NPS), and marijuana. In addition, drug poisoning deaths are the leading cause of injury death in the United States; they are currently at their highest ever recorded level and, every year since 2011, have outnumbered deaths by firearms, motor vehicle crashes, suicide, and homicide.
|Domaine :||Autres substances / Other substances ; Drogues illicites / Illicit drugs|
|Titre suivant :|